This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer's Monsanto Options Play Paid Off

Editor's note: At noon yesterday, Jim Cramer recommended buying January $65 call options (MONAM) in Monsanto (MON) for a trade in his blog. Monsanto was scheduled to post quarterly results this morning, and Cramer expected an upbeat report. The options were priced at just above $8 at the time that Cramer made his blog post and closed yesterday at $9. Meanwhile, Monsanto's shares were trading around $72. After the ag chemicals producer delivered a blowout fiscal first quarter this morning, Monsanto's shares opened nearly 10 points higher, sending the value of the options contracts as high as $19.70. Cramer's post below appeared yesterday on RealMoney. Click here for a free trial, and enjoy incisive commentary all day, every day.

Monsanto Options Look Too Good to Ignore
1/6/2009 12:00 PM EST

Monsanto (MON - Get Report) January 65 calls. Mouthwatering to me. The company reports tomorrow and then goes on a road show next week. They will be talking about their pipeline, and they will be bullish as all get-out. These ag stocks have been slaughtered, and I want to find a way to play the darned thing ahead of the quarter, and I stumble on this contract.

It seems just right for me.

Let me tell you how I would play this from the old hedge fund days. Obviously the stock is getting killed here, hence the opportunity.

I would pick up the calls here. If you get a lift in the common, you sell some common against it, maybe on a 1-to-2 common-to-call ratio in case the bears on the stock are right.

You have a terrific catalyst right in front of you. You have a jazzed management team that has had a stock just destroyed right underneath them.

And, perhaps most important, you have Frank Mitsch, the excellent BB&T chemical analyst, saying the level is right. The calls enable you to low-risk the darned thing because of the nearness of expiration.

I think it is worth the plunge.

Random musings: Reading over the Fortress Investement (FIG) piece on the flagship site, I recall that it was ridiculous when the SEC approved this company to go public. What kind of transparency can a hedge fund really offer? Obviously this was one of the worst deals of all time. Can I just say that I hope the next SEC will actually say no now and then to a company that should not be listed? Or is that too much to ask?

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
MON $117.37 0.57%
AAPL $127.60 2.28%
FB $83.09 2.87%
GOOG $535.38 2.16%
TSLA $205.27 -0.74%

Markets

DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs